更正：蛋白质4.1N作为一种潜在的肿瘤抑制因子，将蛋白磷酸酶1与非小细胞肺癌中的JNK-c-Jun信号通路调节联系起来。
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
作者信息
Wang Zi, Ma Bianyin, Li Hui, Xiao Xiaojuan, Zhou Weihua, Liu Feng, Zhang Bin, Zhu Min, Yang Qin, Zeng Yayue, Sun Yang, Sun Shuming, Wang Yanpeng, Zhang Yibin, Weng Haibo, Chen Lixiang, Ye Mao, An Xiuli, Liu Jing
机构信息
The State Key Laboratory of Medical Genetics and School of Life Sciences, Central South University, Changsha, China.
Department of Medicine, University of California, Irvine, CA, USA.
出版信息
Oncotarget. 2019 Oct 22;10(58):6285. doi: 10.18632/oncotarget.27282.
Abstract
[This corrects the article DOI: 10.18632/oncotarget.6312.].
摘要
[本文更正了文章的数字对象标识符：10.18632/oncotarget.6312。]
相似文献
1
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Oncotarget. 2019 Oct 22;10(58):6285. doi: 10.18632/oncotarget.27282.
2
Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Oncotarget. 2016 Jan 5;7(1):509-23. doi: 10.18632/oncotarget.6312.
3
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
Oncotarget. 2019 Dec 24;10(67):7181-7182. doi: 10.18632/oncotarget.27354.
4
4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
Tumour Biol. 2016 Sep;37(9):12713-12723. doi: 10.1007/s13277-016-5146-3. Epub 2016 Jul 22.
5
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Oncotarget. 2019 Feb 12;10(13):1344. doi: 10.18632/oncotarget.26685.
6
Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.
Lung Cancer. 2018 Jul;121:82-90. doi: 10.1016/j.lungcan.2018.04.024. Epub 2018 May 1.
7
Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Oncotarget. 2019 Aug 6;10(47):4919. doi: 10.18632/oncotarget.27074.
8
Correction: Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.
Oncotarget. 2019 Jan 11;10(4):558. doi: 10.18632/oncotarget.26597.
9
Correction: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
Oncotarget. 2018 Oct 30;9(85):35598. doi: 10.18632/oncotarget.26303.
10
Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival.
Oncotarget. 2021 Oct 26;12(22):2305-2306. doi: 10.18632/oncotarget.28093.
引用本文的文献
1
PKR associates with 4.1R to promote anchorage-independent growth of hepatocellular carcinoma and lead to poor prognosis.
Sci Rep. 2024 Nov 13;14(1):27768. doi: 10.1038/s41598-024-75142-5.
2
The Role of Cytoskeleton Protein 4.1 in Immunotherapy.
Int J Mol Sci. 2023 Feb 14;24(4):3777. doi: 10.3390/ijms24043777.
Zotero 插件